Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension studyHiroyuki Murai, Luiz Augusto da Silva, Yasushi Suzuki et al.|Journal of the Neurological Sciences|2019Cited by 23